PK/PD analysis of biapenem in patients undergoing continuous hemodiafiltration

BACKGROUND: Continuous hemodiafiltration (CHDF) is used as renal replacement therapy for critically ill patients with renal failure, and to treat hypercytokinemia. Since CHDF also clears therapeutic agents, drug pharmacokinetics (PK) should be dependent upon CHDF conditions. Although the antibiotic...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:J Pharm Health Care Sci
Prif Awduron: Akashita, Gaku, Hosaka, Yuto, Noda, Toru, Isoda, Kazuya, Shimada, Tsutomu, Sawamoto, Kazuki, Miyamoto, Ken-ichi, Taniguchi, Takumi, Sai, Yoshimichi
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: BioMed Central 2015
Pynciau:
Research Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC4728804/
https://ncbi.nlm.nih.gov/pubmed/26819742
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40780-015-0031-6
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg